Veracyte, J&J Launch NOBLE Trial For Lung Cancer Detection
The 9,000-patient clinical study will identify genomic and other differences in lung cancer development and progression among patients with lung nodules detected by computed tomography.
You may also be interested in...
Optellum’s Virtual Nodule Clinic artificial intelligence technology will be part of Johnson & Johnson’s Lung Cancer Initiative, an ongoing research program intended to improve lung cancer survival rates through early intervention and prevention.
With the addition of Decipher, Veracyte now offers tests for seven of the 10 most common types of cancer in the US.
Johnson & Johnson has entered a strategic collaboration with genomics diagnostics company Veracyte to develop and commercialize tests for detecting lung cancer.